Hari Cure Pharmaceuticals Private Limited
About Hari Cure Pharmaceuticals Private Limited
Data last updated:
Hari Cure Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 03 August 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2004PTC010878. Its GSTIN is 10AACCH0034J2ZA (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors Rakesh Ranjan Upadhayay and Anjali Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/O Sri Hariji Upadhyaymithapur Muslim Lane, Patna, Bihar, India – 800001.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.07 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹360 (net margin 0%) and EBITDA of ₹2.74 Lakh (EBITDA margin 30.2%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hari Cure Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH/O Sri Hariji Upadhyaymithapur Muslim Lane, Patna, Bihar, India – 800001
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Hari Cure Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hari Cure Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Hari Cure Pharmaceuticals Private Limited, buy the company report.
Financials of Hari Cure Pharmaceuticals Private Limited
FY 2025 filings availableHari Cure Pharmaceuticals Private Limited reported revenue of ₹9.07 Lakh (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 30% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹360 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.2% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hari Cure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hari Cure Pharmaceuticals Private Limited
Hari Cure Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Ranjan Upadhayay | Director | 03 Aug 2004 | 22 Years 2 Months | Current |
| Anjali Upadhyay | Director | 14 Jan 2025 | 1 Years 9 Months | Current |
Auditor
Hari Cure Pharmaceuticals Private Limited is audited by ALOK SHARMA & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALOK SHARMA & CO | FY 2017 | 009108N |
Shareholding
The shareholding of Hari Cure Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Hari Cure Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hari Cure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hari Cure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hari Cure Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCH0034J2ZA | Bihar | Active | 02 Apr 2018 |
To see the full GST registrations and return filing status of Hari Cure Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hari Cure Pharmaceuticals Private Limited has 4 board changes on record since 2004: 3 appointments and 1 cessation. The latest: Akhilesh Kumar Upadhyay ceased to be Director on 14 Jan 2025.
Frequently asked questions
Hari Cure Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in wholesale, within the trading industry. It was incorporated on 03 August 2004 (22+ years old) and is registered under CIN U24230BR2004PTC010878.
Hari Cure Pharmaceuticals has 2 current directors:
- Rakesh Ranjan Upadhayay - Director
- Anjali Upadhyay - Director
The latest financial statements of Hari Cure Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hari Cure Pharmaceuticals is 10AACCH0034J2ZA, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Hari Cure Pharmaceuticals is U24230BR2004PTC010878. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hari Cure Pharmaceuticals was incorporated on 03 August 2004, making it 22+ years old. It is registered with the Registrar of Companies, Patna.
Akhilesh Kumar Upadhyay ceased to be Director on 14 Jan 2025. Anjali Upadhyay was appointed as Director on 14 Jan 2025. Akhilesh Kumar Upadhyay was appointed as Director on 03 Aug 2004. Hari Cure Pharmaceuticals has 4 board changes on record in total.
The registered office of Hari Cure Pharmaceuticals is at HO Sri Hariji Upadhyaymithapur Muslim Lane, Patna, Bihar, India – 800001.
Hari Cure Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Hari Cure Pharmaceuticals is compliant as of 27 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
